Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

Digitalization in Drug Discovery Presents Significant Growth Opportunities for Healthcare IT Companies

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutions have just started to grow, with companies primarily looking at data analytics and AI-based solutions to the improve efficiency of their research operations. As adoption of IT solutions grows and vendors develop clarity about customer requirements, the market is expected to witness a transformation in existing product landscape and available opportunities. At presen

Key Features

This research publication aims to provide insights on existing and emerging growth opportunities in the global pharmaceutical drug discovery IT solutions market. It covers qualitative and quantitative market insights on overall spend of pharmaceutical companies on drug discovery IT solutions, key market segments, and their spending breakdown, adoption level of IT solutions by top 10 pharmaceutical companies in their drug discovery operations and highlights of their existing operations. The research study further delves into key market segments and associated opportunities, competitive landscape and key participants in the market.

Key Issues Addressed

  • What is the current market landscape and expected growth in the IT spend of pharmaceutical companies in their drug discovery operations?
  • What are the key long-term and short-term opportunities that can be capitalized upon by existing market players and potential entrants?
  • What is the current adoption level of drug discovery IT solutions in the pharmaceutical industry? What initiatives have been taken by Big Pharma companies?
  • What is the current competitive landscape of the market? How are different participants positioned in this segment?
  • What are the key market trends and how are they impacting the overall market landscape?

Table of Contents

Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020Executive SummaryKey FindingsMarket Engineering MeasurementsMarket Engineering Measurements (continued)Market Definitions and OverviewMarket Definition—Drug Discovery IT SolutionsMarket Overview and LandscapeScope and SegmentationKey Questions Addressed in this StudyDrivers and RestraintsMarket DriversDrivers for ICT Adoption in Drug Discovery OperationsMarket RestraintsRestraints for ICT Adoption in Drug Discovery OperationsForecast and TrendsForecast Assumptions—Global Pharmaceutical R&D IT MarketMarket Engineering Measurements—Pharmaceutical R&D IT MarketRevenue Forecast—Pharmaceutical R&D IT MarketGlobal Pharmaceutical R&D IT Spend by FunctionGlobal Pharmaceutical R&D IT Market—Regional BreakdownRevenue Forecast DiscussionForecast Assumptions––Global Drug Discovery IT Solutions MarketMarket Engineering Measurements––Pharmaceutical Drug Discovery IT Solutions MarketRevenue Forecast––Pharmaceutical Drug Discovery IT Solutions MarketPharmaceutical Drug Discovery IT Solutions Market Breakdown by Key SegmentsRevenue Forecast DiscussionKey Market Trends and Their Impact on BusinessGlobal Pharmaceutical Drug Discovery IT Solutions––Key Trends and Impact on BusinessGlobal Pharmaceutical Drug Discovery IT Solutions––Key Trends ExplainedGlobal Pharmaceutical Drug Discovery IT Solutions––Key Trends Explained (continued)Global Pharmaceutical Drug Discovery IT Solutions––Key Trends Explained (continued)Current Adoption of IT Solutions in Pharmaceutical R&DIT Adoption Level Across Different Functions––Drug Discovery and Clinical Development ProcessIT Solutions Adoption Levels In the Pharmaceutical IndustryKey Initiatives by Big Pharmaceutical CompaniesKey Initiatives by Big Pharmaceutical Companies (continued)Key Initiatives by Big Pharmaceutical Companies (continued)Highlights of IT Tools Adoption in Drug Discovery ApplicationsHighlights of IT Tool Adoption in Drug Discovery Applications (continued)Product/Service Life Cycle Analysis of Major IT SolutionsKey Market Growth Opportunities––Segments to WatchSegments to Watch––Medicinal Chemistry MarketSegments to Watch––Genomics (NGS Informatics Market)Segments to Watch––Genomics (Machine Learning in Genomics)Segments to Watch––Pharmacovigilance and Drug Safety IT SolutionsCompetitive AnalysisCompetitive EnvironmentCompetitive Factors Assessment Key Companies to WatchKey Companies to Watch (continued)Conclusion3 Key OpportunitiesStrategic ImperativesLegal DisclaimerThe Frost & Sullivan StoryThe Journey to Visionary Innovation The Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.